YaylaCKaranfilMErtemAGAcarBUnalSAkbogaMK. Inflammation parameters in aortic aneurysm. Angiology. 2019;70(3):280.
2.
ShimizuKMitchellRNLibbyP. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2006;26(5):987–94.
3.
DaleMARuhlmanMKBaxterBT. Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy. Arterioscler Thromb Vasc Biol. 2015;35(8):1746–55.
4.
LiHBaiSAoQ. Modulation of immune-inflammatory responses in abdominal aortic aneurysm: emerging molecular targets. J Immunol Res. 2018;2018:7213760.
5.
CurciJAThompsonRW. Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context?J Clin Invest. 2004;114(2):168–71.
6.
DavisFMRateriDLDaughertyA. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart. 2014;100(19):1498–505.
7.
GuoDCPapkeCLHeRMilewiczDM. Pathogenesis of thoracic and abdominal aortic aneurysms. Ann N Y Acad Sci. 2006;1085:339–52.
8.
BalmforthDHarkyAAdamsB. Is there a role for biomarkers in thoracic aortic aneurysm disease?. Gen Thorac Cardiovasc Surg. 2019;67(1):12–9.
9.
Flondell-SiteDLindbladBKolbelTGottsaterA. Cytokines and systemic biomarkers are related to the size of abdominal aortic aneurysms. Cytokine. 2009;46(2):211–15.
10.
JuvonenJSurcelHMSattaJ. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1997;17(11):2843–7.
11.
Flondell-SiteDLindbladBGottsaterA. High levels of endothelin (ET)-1 and aneurysm diameter independently predict growth of stable abdominal aortic aneurysms. Angiology. 2010;61(4):324–8.
FolsomARYaoLAlonsoA. Circulating biomarkers and abdominal aortic aneurysm incidence: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2015;132(7):578–85.
14.
GolledgeJTsaoPSDalmanRLNormanPE. Circulating markers of abdominal aortic aneurysm presence and progression. Circulation. 2008;118(23):2382–92.
15.
BaltaSCelikTMikhailidisDP. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost. 2016;22(5):405–11.
16.
UzunFErturkMCakmakHA. Usefulness of the platelet-to-lymphocyte ratio in predicting long-term cardiovascular mortality in patients with peripheral arterial occlusive disease. Postepy Kardiol Interwencyjnej. 2017;13(1):32–8.
17.
DuRLiDYuJ. Association of platelet to lymphocyte ratio and risk of in-hospital mortality in patients with type B acute aortic dissection. Am J Emerg Med. 2017;35(2):368–70.
18.
BhuttaHAghaRWongJTangTYWilsonYGWalshSR. Neutrophil-lymphocyte ratio predicts medium-term survival following elective major vascular surgery: a cross-sectional study. Vasc Endovascular Surg. 2011;45(3):227–31.
19.
AppletonNDBaileyDMMorris-StiffGLewisMH. Neutrophil to lymphocyte ratio predicts perioperative mortality following open elective repair of abdominal aortic aneurysms. Vasc Endovascular Surg. 2014;48(4):311–6.
20.
KordzadehAMalietzisGBrowneTPrionidisIPanayiotopoulosYP. Neutrophil to lymphocyte ratio (NLR) of five predicts 30-day morbidity in ruptured abdominal aortic aneurysms (rAAA): a retrospective cohort study. Int J Surg. 2015;15:45–8.
21.
LareyreFRaffortJLeD. High neutrophil to lymphocyte ratio is associated with symptomatic and ruptured thoracic aortic aneurysm. Angiology. 2018;69(8):686–91.
22.
AkbogaMKCanpolatUYaylaC. Association of platelet to lymphocyte ratio with inflammation and severity of coronary atherosclerosis in patients with stable coronary artery disease. Angiology. 2016;67(1):89–95.
23.
LareyreFCarboniJChikandeJ. Association of platelet to lymphocyte ratio and risk of 30-day postoperative complications in patients undergoing abdominal aortic surgical repair [Published online ahead of print January 1, 2018]. Vasc Endovascular Surg. DOI; 10.1177/1538574418789046
24.
CagliKTokDTurakO. Monocyte count-to-high-density lipoprotein-cholesterol ratio is associated with abdominal aortic aneurysm size. Biomark Med. 2016;10(10):1039–47.
